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Abstract
Introduction In recent years, there has been an increase
in the number of patients with squamous cell carcinoma
(SCC) of the mobile tongue in the absence of tobacco and
alcohol. The literature suggests that human papilloma virus
(HPV) may be involved in the development of SCC of the
head and neck, especially in non-smoking and non-drinking
patients. In the oral cavity, however, the presence of the
HPV genome has been reported with various percentages.
This may be due to misclassification of the oropharyngeal
tongue as oral cavity subsite and the use of various
detection methods.
Materials and methods Therefore, we evaluated the role of
HPV in seven consecutive non-smoking and non-drinking
patients (2003–2006) with a SCC located at the oral, mobile
tongue using in situ hybridization and SPF10Line Blot 25
polymerase chain reaction assays.
Results No HPV was detected in these specimens. To further
determine whether a relationship exists between HPV and
SCC in the absence of tobacco and alcohol, subsequent
studies at specific locations are necessary.
Keywords Human papilloma virus . Oral cancer
Introduction
Oral cavity cancer is the eighth most common malignancy
worldwide, with more than 300,000 new cases annually [1].
Although it is generally agreed that long-term tobacco,
alcohol and betel quid consumption are the major environ-
mental risk factors for the development of oral squamous
cell carcinoma (SCC) [1, 2], in recent years, the Nether-
lands have seen an increase in the number of patients with
an SCC of the mobile tongue in the absence of tobacco and
alcohol. This rise is in line with studies suggesting that the
incidence of tongue and tonsillar cancer is increasing in
patients who have had no exposure to these traditional
risk factors or with an exposure time not long enough for
malignant transformation [2–4].
Nowadays, the question arises whether there is a possible
association between this increased incidence of SCC of the
tongue and tonsil and high-risk human papilloma virus (HR-
HPV) infection. It is generally accepted that there is a strong
association between tonsillar SCC and HR-HPV [5–8].
However, with regard to the oral cavity, no unambiguous
conclusions can yet be drawn as to whether HR-HPV also
plays a role in the development of oral SCC [2, 5, 9]. The
International Agency for Research on Cancer multicentre
study by Herrero et al. [10] detected HR-HPV DNA in
3.9% of the biopsy specimens of the oral cavity, whereas a
large population-based review study conducted by Kreimer
et al. [11] reported that the HR-HPV prevalence in SCC of
the oral cavity was 23.5%.
The literature suggests that the variety of results can be
attributed to geographical differences [2], different detec-
tion methods and their sensitivity [2, 12], but also to a
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misclassification of the oropharyngeal tongue, which is
considered part of Waldeyer’s tonsillar ring, as oral cavity
subsite [2, 7, 10]. It has been suggested that this ring might
be particularly susceptible to HPV, and therefore, cancer
site misclassification is considered to be a serious problem
that may bias risk estimates in many epidemiological
studies [2].
To evaluate the oncogenetic role of HR-HPV in an
absolute non-smoking and non-drinking patient group with
an oral SCC of the mobile tongue, a case study was
performed using two different detection methods.
Materials and methods
Clinical data concerning consecutive Dutch patients with
histologically confirmed primary SCC of the mobile tongue,
treated between 2003 and 2006, were obtained from the
medical charts of the Department of Oral and Maxillofacial
Surgery, Radboud University Nijmegen Medical Centre
(RUNMC), The Netherlands. Patients who had been exposed
to radiotherapy and chemotherapy in their history because of
another oncological problem were excluded. Only patients
who have never smoked and consumed alcoholic beverages
up to one unit a day were included. These patients were
screened for tobacco and alcohol use in their history, with a
detailed retrospective review of the charts of the hospitals, of
general dental practitioners and of general practitioners. This
was confirmed by direct communication with the patient or
close family. In addition, other data concerning sex, age at
diagnosis, tumor histology, and tumor–node–metastases
classification (according to the International Union Against
Cancer) were obtained from their medical charts.
Consequently, the paraffin-embedded tissue resections
from seven consecutive patients were retrieved from the
archives of the Department of Pathology, RUNMC. For each
patient, a total of three stained microscopic sections were
evaluated; one section was stained with haematoxylin
and eosin, two stained for the detection of HPV. It was
determined which sections of each tumour were most
suitable for inclusion in our study, based on the presence of
sufficient numbers of tumour cells, the absence of damaged
malignant tissue and, where possible, the presence of normal
and/or dysplastic epithelium for comparison purposes. These
obtained specimens were tested by in situ hybridization
(ISH) [13] (HPV 16/18 and 31/33) and a short polymerase
chain reaction (PCR) Fragment-PCR (SPF10Line Blot 25
PCR) [14] assay. This PCR assay amplifies a fragment of
only 65 bp and is therefore considered a highly sensitive
detection method for different HPV types (up to 43
individual HPV-types) on paraffin-embedded specimens in
particular [14, 15]. Consequently, this combined detection–
genotyping assay is used in the routine clinical practice of
screening cervical scrapes and oral and cervical research
applications [14, 16]. The integrity of the extracted DNA
was also determined by amplification of the β-globin gene,
which also served as an internal amplification check.
To avoid cross-contamination with HPV, all tissue
specimens were processed separately. A tissue block from
a confirmed HR-HPV-positive tonsil carcinoma was used as
a positive control. Both assays were performed as previ-
ously described [13, 14].
Results
No HR-HPV was detected in the primary tumours of the
seven consecutive non-smoking and non-drinking Dutch
patients using ISH and SPF10Line Blot 25 PCR assays
(Table 1).
Discussion
We evaluated the oncogenetic role of HR-HPV in an
absolute non-smoking and non-drinking patient group with
an oral SCC of the mobile tongue using two different
detection methods. According to the literature, there are two
specific European studies that differentiate between SCC of
the oral tongue and carcinomas originating from the base of
the tongue [17, 19]. Kantola et al. [17] could not detect HR-
HPV in 105 specimens of the oral tongue, whereas Dahlgren
et al. [19] found only two of the 85 analysed mobile tongue
cancers to be HR-HPV positive. However, it remains unclear
if these studies included absolute non-smoking and non-
drinking patients.
Table 1 Patient data
Follow-up interval: months
1 Yes, 0 no
Age Sex Pathology stage Recurrence Survival Follow-up interval
23 Female pT1N0 M0 1 0 10
49 Male pT1N0 M0 0 1 40
95 Female pT3N0 M0 0 1 38
44 Male pT3N1 M0 0 1 24
37 Male pT1N0 M0 0 1 37
56 Female pT1N0 M0 1 1 26
40 Female pT2N0 M0 0 1 57
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Based on the literature, infection with HR-HPV has been
suggested as a risk factor for the development of SCC of
the head and neck (HNSCC) in non-smoking patients [2,
10, 12]. Yet almost all studies known in the absence of
tobacco and alcohol were conducted in HNSCC in general
[18, 21]. In a study by Dahlstrom et al. [18], 60 non-
smoking patients with a developed HNSCC were evaluated
for the presence of HR-HPV. Nevertheless, 17 of these
patients appeared to have an SCC of the oral tongue, and
only one appeared to be HR-HPV positive. These results
seem to be in line with the results of our study. However,
the results of the study by Dahlstrom et al. [18] were based
on serological antibody testing which is not considered
a standard method because of the low sensitivity and
specificity of the assays [20].
According to the literature, the various reported HPV
percentages in the oral cavity may be due to the different
sampling and detection methods used [2, 12]. For instance,
according to McKaig et al. [22], the HPV prevalence in
HNSCC as detected by PCR was 34.5%, by ISH 15.8%,
and by Southern blot 24.5%. According to Gillison [23],
ISH assays may have limited sensitivity for some HPV
types, and therefore, the validity of the prevalence data is
unproven. It has been suggested that conventional PCR-
based assays can be hampered in archival smears or paraffin-
embedded materials [15, 24]. Therefore, we used SPF PCR
primers that permit 100% detection of HPV DNA in
paraffin-embedded materials [15, 25].
Based on the results found in our case study and the
results found by Dahlstrom et al. [18], Kantola et al. [17]
and Dahlgren et al. [19], it seems that HR-HPV is not
involved in the development of SCC of the oral tongue.
However, to further determine whether a relationship exists
between HR-HPV and OSCC in the absence of tobacco and
alcohol, further research is necessary. To ease comparability
between different studies, it seems recommendable to take
into account the type of detection assays and misclassifica-
tion of anatomical tumour sites.
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